Landscapes / Companies
Mesoblast, Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
2 active
3 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cell therapy |
Mesoblast |
Approved | 28 Feb 2028Phase 3 trial completes | ||
| How it works | A cell therapy | ||||
| Next date | 28 Feb 2028 · Phase 3 trial completes | ||||
| Also tested for | GVHD - Graft-Versus-Host Disease | ||||
| Open drug page | |||||
Cell therapy |
Phase 3 | Jul 2027Phase 3 trial completes | |||
| How it works | A cell therapy | ||||
| Next date | Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Degenerative Disc Disease | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021